If you're making headway on your health goals on your current dose, there's no real reason to increase the dose and potentially harm your progress
For some reason, and I can find no scientific basis for this, that recommendation was changed in 1974 to an injection every two months and then in 1984 to every three months
Theoretically, similar interactions may occur between indinavir and other thyroid hormones, given that both T4 and T3 are metabolized to some degree via hepatic UDP-glucuronosyl transferase
Another real-world study published in PMC examined patients with type 2 diabetes and confirmed that tirzepatide users had greater HbA1c and weight reductions at 12 months compared to injectable semaglutide users, regardless of whether they had previous GLP-1 receptor agonist experience
However, in individuals suffering from different neurodevelopmental disorder conditions, including ASD, these pathways can be hyperactivated, causing irreversible damage to the organism
However, the authors of this study noted that there were no clinically significant differences, and both drugs were effective for their intended uses